These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 12915191)

  • 21. General toxicology of MnDPDP.
    Larsen LE; Grant D
    Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
    Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
    Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.
    Hamoud AK; Khan MF; Aboalmaali N; Usadel KH; Wullstein C; Vogl TJ
    Eur Radiol; 2004 May; 14(5):923-5. PubMed ID: 12955450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manganese toxicity upon overexposure.
    Crossgrove J; Zheng W
    NMR Biomed; 2004 Dec; 17(8):544-53. PubMed ID: 15617053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
    Traoré AS; Godbout MJ; Serre D; Younan R; Dionne G; Dufour M; Morin J; Moisan C
    Magn Reson Imaging; 2003 Jul; 21(6):609-15. PubMed ID: 12915191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
    Mathieu D; Coffin C; Kobeiter H; Caseiro-Alves F; Mahfouz A; Rahmouni A; Diche T
    J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
    Ni Y; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
    Ahlström H; Gehl HB
    Acta Radiol; 1997 Jul; 38(4 Pt 2):660-4. PubMed ID: 9245961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
    Schima W; Függer R
    Eur Radiol; 2002 Dec; 12(12):2998-3008. PubMed ID: 12439582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.